Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 72162-1527
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 72162-1527). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image Description (Lbl721621527)
This text appears to be a label or description for a medication called buPROPion Hydrochloride Extended-Release Tablets. Each tablet contains 300 mg of the active ingredient, bupropion HCL. The medication is meant to be taken orally, with one tablet per day or as directed by a physician. There is a warning not to use this medication in combination with Zyban or any other medicines that contain bupropion HCI. The text also includes information on how to store the medication and provides links to instructions for use and a medication guide. The label indicates that the medication is manufactured by ScieGen Pharmaceuticals, Inc. and relabeled by Bryant Ranch Prepack, Inc. Located in Burbank, CA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.